rgenix cancer therapeutics company focuses on rna to identify novel targets
Published 4 years ago • 387 plays • Length 10:23Download video MP4
Download video MP3
Similar videos
-
4:49
futex2021－conference：bpr1r series: novel csf1r inhibitors as cancer immunomodulatory agents
-
49:15
2016 wmif | epigenetics and novel cancer targets
-
54:36
precision medicine part ii: the gene’s role in cancer treatment | focus on cancer s1e6
-
30:16
nccm 2024 | epigenetic profiling of biomarkers for cancer risk assessment by dr zdenko herceg
-
21:51
the future of oncolytic viruses and bracelet-1 breast cancer study.
-
8:18
novel nootropic: fonturacetam hydrazide (phenylpiracetam derivative) - for mood, focus & energy.
-
5:03
tumour immunology and immunotherapy
-
1:14
new framework for drug-free cancer therapies
-
1:01
an update on the phase i trial of bms-986393, a novel gprc5d-targeted car-t, in r/r myeloma
-
8:29
part 4: novel adcs including her3 and novel nectin-4
-
9:15
cancer as regulatory disease
-
1:48
post hoc keynote-040 analysis: pembrolizumab for hnscc produces lasting immune effect
-
2:58
tomorrow’s breakthroughs today: immunotherapy and the cancer research institute
-
25:27
nccm 2024 | enhancing skills based training in screening, diagnosis and treatment by dr flora chong
-
4:32
novel advances in the management of gc/gejc
-
2:11
competency frameworks for cancer nursing
-
1:49
novel potential huntington’s treatments
-
1:48:10
cancer & i - hormonal horoscope: a glimpse into the relationship between hormones and cancers
-
3:07
cancer: the future of a cure
-
30:45
novel non immunotherapy targets and agents in gastroesophageal cancer